Loading provider…
Loading provider…
Medical Oncology Physician in Washington, DC
NPI: 1154610467Primary Practice Location
MEDSTAR GEORGETOWN UNIVERSITY HOSPITAL
3800 Reservoir Rd NW, Washington, DC
Primary Employer
Regional Cancer Care Associates, L.L.C.
regionalcancercare.org
HQ Phone
Get MD Kieron's Phone NumberMobile
Get MD Kieron's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardDC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 112 | 297 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 45 | 210 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 29 | 37 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 28 | 28 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 25 | 28 |
Authors: Mark Roschewski, Wyndham Wilson, Milos Miljkovic
Journal: Leuk Lymphoma
Publication Date: 2019-06-17
Authors: Jean Yared, Saurabh Dahiya, Aaron Rapoport, Wengen Chen, Djordje Atanackovic, Silke Niederhaus, Michael Kallen
Journal: Hum Vaccin Immunother
Publication Date: 2023-06-06
Lead Sponsor: Georgetown University
Collaborators: AbbVie, Pharmacyclics LLC., Hackensack Meridian Health
Intervention / Treatment: DRUG: Venetoclax, DRUG: Ibrutinib
Lead Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Cyclophosphamide, DRUG: Prednisone, DRUG: Etoposide, DRUG: Vincristine Sulfate, BIOLOGICAL: Rituximab, BIOLOGICAL: Filgrastim, DRUG: Doxorubicin Hydrochloride, BIOLOGICAL: Lentivirus Vector rHIV7-shI-TAR-CCR5RZ-transduced Hematopoietic Stem/Progenitor Cells
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Flavopiridol